Kyowa Kirin funds independent research and education in rare hematologic cancers, bone and mineral diseases, and advanced therapies to advance science and patient outcomes.
Funder: Kyowa Kirin
Due Dates: June 15, 2026
Funding Amounts: $5,000–$100,000 per project; typically for 1-year initiatives
Summary: Supports independent research, education, and patient advocacy initiatives in rare hematologic cancers, bone and mineral diseases, and advanced therapeutic modalities.
Kyowa Kirin offers grants to support independent research, medical education, and patient advocacy programs that align with their focus on rare hematologic cancers, bone and mineral diseases, and advanced therapies such as antibodies and gene therapies. The program aims to foster new scientific data, improve medical education, empower patients, and influence public health policy. Funding is available for a range of activities, including independent medical education, fellowships, data collection, disease registries, investigator-sponsored research, and patient awareness or outreach initiatives. The grants are awarded through an arms-length agreement to ensure independence and integrity.